Mangoceuticals
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-58.69K-519.95-0.64N/A-519.95
Price/Sales ratio
N/A116.22K8.10N/A116.22K
Price/Book Value ratio
-62.13K1.69K7.64N/A1.69K
Price/Cash Flow ratio
-59.29K-771.54-0.84N/A-771.54
Price/Free Cash Flow ratio
-59.29K-747.61-0.84N/A-747.61
Price/Earnings Growth ratio
N/A-0.04-0.00N/A-0.04
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A54.25%58.98%N/A54.25%
Operating Profit Margin
N/A-22279.69%-1260.28%N/A-22279.69%
Pretax Profit Margin
N/A-22352.10%-1259.39%N/A-22352.10%
Net Profit Margin
N/A-22352.10%-1259.39%N/A-22352.10%
Effective Tax Rate
395.90%11.24%N/AN/A11.24%
Return on Assets
-78.49%-199.15%-876.71%N/A-199.15%
Return On Equity
105.86%-325.40%-1189.07%N/A-325.40%
Return on Capital Employed
104.78%-268.15%-1097.85%N/A-268.15%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
0.572.663.78N/A2.66
Cash ratio
0.572.623.50N/A2.62
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A22.51N/AN/A
Operating Cycle
N/AN/A22.51N/AN/A
Days of Payables Outstanding
N/A3.00K171.26N/A3.00K
Cash Conversion Cycle
N/A-3.00K-148.75N/A-3.00K
Debt Ratios
Debt Ratio
1.740.160.06N/A0.16
Debt Equity Ratio
-2.340.270.08N/A0.27
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A
Total Debt to Capitalization
1.740.210.07N/A0.21
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.44-8.04-109.81N/A-8.04
Company Equity Multiplier
-1.341.631.35N/A1.63
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-150.63-9.56N/A-150.63
Free Cash Flow / Operating Cash Flow Ratio
11.031.00N/A1.03
Cash Flow Coverage Ratio
-0.44-8.04-109.81N/A-8.04
Short Term Coverage Ratio
-0.44-8.04-109.81N/A-8.04
Dividend Payout Ratio
N/AN/AN/AN/AN/A